HEALTHCARE INSIGHTS
HEALTHCARE INSIGHTS
  • Home
  • #Global Trends
  • #Vietnam
  • #M&A
  • #Regulations
  • #Knowledge
    • #Corporate Wellness
    • #Human Resources
    • #Capability Development
    • #Personal Health
  • Newletter
  • Events
    HEALTHCARE INSIGHTS
    HEALTHCARE INSIGHTS
    • Home
    • #Global Trends
    • #Vietnam
    • #M&A
    • #Regulations
    • #Knowledge
      • #Corporate Wellness
      • #Human Resources
      • #Capability Development
      • #Personal Health
    • Newletter
    • Events

    Category: Uncategorized

    Ho Chi Minh City launches Gia Dinh People’s Hospital – Campus 2 at prime location

    31/12/2025 Published by vivi

    Healthcare infrastructure upgrade through strategic merger On the morning of December 31, 2025, Ho Chi Minh City officially inaugurated Campus... Read more

    Category: Uncategorized
    Tags: #Vietnam

    Leading Through Volatility: Transforming Anxiety into Focus

    31/12/2025 Published by vivi

    The Triple Engines of Leadership Fear Uncertainty has shifted from occasional shocks to an ambient rhythm of disruption. Policy Volatility:... Read more

    Category: Uncategorized
    Tags: #Human Resources

    Strategic Governance: Cultivating Alliance Amidst Global Turbulence

    30/12/2025 Published by vivi

    Establishing "Certainty Bubbles" for Stakeholders As global economic policy uncertainty reaches a thirty-year peak, corporations frequently default to internal survival... Read more

    Category: Uncategorized
    Tags: #Human Resources

    Novo Nordisk slashes Wegovy prices in China ahead of patent cliff

    30/12/2025 Published by vivi

    Strategic price cuts to bolster market dominance The Danish pharmaceutical giant Novo Nordisk has significantly reduced the price of its... Read more

    Category: Uncategorized
    Tags: #Global Trends

    Sanofi faces FDA rejection for Multiple Sclerosis drug Tolebrutinib

    30/12/2025 Published by vivi

    Unexpected setback from the U.S. regulator In a surprising turn of events, Sanofi received a Complete Response Letter (CRL) from... Read more

    Category: Uncategorized
    Tags: #Global Trends

    J&J discontinues atopic dermatitis drug trial following $1.25B acquisition

    30/12/2025 Published by vivi

    Efficacy shortfall in DUPLEX-AD study Johnson & Johnson (J&J) has decided to halt the Phase 2 clinical trial of its... Read more

    Category: Uncategorized
    Tags: #Global Trends

    Senhwa Biosciences enters global ADC market with novel combination therapy

    30/12/2025 Published by vivi

    Synergy between G4 Stabilizer and leading ADC technology Senhwa Biosciences has reached a clinical milestone by initiating a Phase 1b... Read more

    Category: Uncategorized
    Tags: #Global Trends

    EirGenix licenses Transcenta’s HiCB platform to revolutionize bioprocessing

    30/12/2025 Published by vivi

    Strategic partnership for advanced biomanufacturing Transcenta Therapeutics and EirGenix Inc. have entered into a strategic non-exclusive licensing agreement, granting EirGenix... Read more

    Category: Uncategorized
    Tags: #Global Trends

    Akari Therapeutics initiates GMP manufacturing for breakthrough ADC AKTX-101

    30/12/2025 Published by vivi

    A pivotal step toward Phase 1 clinical trials Akari Therapeutics has officially launched GMP (Good Manufacturing Practice) activities for its... Read more

    Category: Uncategorized
    Tags: #Global Trends

    Posts pagination

    Previous page Page 1 … Page 195 Page 196 Page 197 … Page 225 Next page

    Facebook

    Map

    Workday: Monday to Friday
    Working hours: 8am to 5pm
    Address: 8th floor, Hyco 4 building, 205A Nguyen Xi Street, Binh Thanh Ward, HCMC

    Please enable JavaScript in your browser to complete this form.
    Get Your Weekly Market Insights Stay informed on Vietnam's market & Healthcare Alliance updates
    Loading

    Online Members

    Recent Comments

    • GauTruc on New Biotech Startup Secures $125 Million to Advance Pain Medication
    HEALTHCARE INSIGHTS
    All rights reserved